Does BuSpar Cause Weight Gain? What the Data Shows
Clinically reviewed by Daniel Montville, MD
Reviewed October 21, 2026 · Last updated September 30, 2026
Key Takeaways
- Buspirone's label lists weight gain as an infrequent side effect, meaning it was reported in roughly 1 in 100 to 1 in 1,000 people during premarketing studies. Weight loss appears at the same frequency, and neither showed up in the placebo-controlled side effect table.
- Buspirone's label names serotonin 5-HT1A and dopamine D2 receptors as its main targets and doesn't list histamine H1, the receptor most closely tied to weight gain with antipsychotics. That helps explain why it's considered weight-neutral.
- A 2026 analysis of FDA adverse event reports found 19 reports mentioning obesity among 1,744 buspirone reports. Spontaneous reports can flag a signal but can't prove that buspirone caused the weight change.
- When weight changes on BuSpar, look at the whole picture: an SSRI taken alongside it, returning appetite as depression or anxiety improves, and changes in sleep or drinking are all more common explanations.
You finally found an anxiety medication that doesn’t leave you foggy, and now the scale is moving. Or you’re about to start BuSpar after an antidepressant changed your weight, and you don’t want to go through that again. Either way, you deserve a straight answer about buspirone and weight, backed by numbers.
Weight gain from psychiatric medications usually traces back to specific receptors in your brain. A 2003 receptor-binding study of 17 antipsychotics found that how strongly each drug blocked the histamine H1 receptor tracked short-term weight gain more closely than any other receptor it measured. The buspirone prescribing information names serotonin 5-HT1A receptors, and to a lesser degree dopamine D2 receptors, as buspirone’s main targets, and histamine H1 isn’t among them. That precision is the first clue to why weight gain is uncommon on it.
Worry about weight on psychiatric medication is well founded. In a UK cohort study of nearly 300,000 adults, people prescribed antidepressants had a 21% higher rate of gaining at least 5% of their body weight, and the added risk lasted for at least six years. The concern is real, and the data behind it are solid.
But buspirone works differently from those drugs, and at Siggy we’d rather show you its own numbers than lump it in with every medication that has changed someone’s weight. This guide covers what buspirone’s label reports, what real-world safety reports suggest, a stomach effect that may shift appetite for some people, and the more common reasons weight changes during anxiety treatment. It ends with what to track if the scale moves. Whether a weight change belongs to buspirone or to something else is ultimately a question of evidence.
What This Page Covers
- What Does the BuSpar Label Say About Weight?
- What the Data Shows Side by Side
- Could BuSpar Change Your Appetite?
- Why People Gain Weight While Taking BuSpar
- What to Do If the Scale Moves
- When to Call Your Prescriber or 911
What Does the BuSpar Label Say About Weight?
Buspirone is FDA-approved to manage anxiety disorders, and its label draws on premarketing studies in more than 3,500 people. The label reports side effects from two kinds of data, and weight shows up in only one of them.
The first is the placebo-controlled table, pooled from 17 four-week trials. It lists every side effect reported by at least 1% of people on buspirone. Weight gain, weight loss, and appetite changes aren’t on it. The most common entries were dizziness (12% versus 3% on placebo), nausea (8% versus 5%), and headache (6% versus 3%).
The second is a broader list from about 3,000 people who took buspirone during premarketing studies, including open and uncontrolled settings. Here, the label defines “infrequent” as events in 1 in 100 to 1 in 1,000 people, and it lists all of the following as infrequent:
- Weight gain
- Weight loss
- Increased appetite
- Decreased appetite (anorexia)
- Swelling (edema)
These bands describe how often an event was reported, not a precise rate. The list also comes without a comparison group, so the label notes that a causal link to buspirone can’t be determined for these events. The label also describes 264 people who took buspirone for a year without ill effect. Our guide to BuSpar side effects covers the more common early effects in detail.
What the Data Shows Side by Side
Each type of evidence answers a slightly different question. The table below compares the three most relevant sources: the label’s premarketing data, a 2026 adverse event analysis, and a controlled stomach-function study.
| Source | What It Found | Main Limit |
|---|---|---|
| Label, about 3,000 people | Weight gain infrequent, 0.1% to 1% | No comparison group |
| FDA reports, 2006 to 2025 | 19 obesity reports among 1,744 | Can’t prove cause |
| Stomach study, 17 patients | Relaxed stomach, less early fullness | Weight not measured |
The 2026 analysis searched the FDA Adverse Event Reporting System from 2006 to early 2025. Among 1,744 reports involving buspirone, dizziness and anxiety were the most frequent, and 19 reports mentioned obesity. The authors called this a rare but noteworthy signal worth further study. Reports like these are submitted voluntarily and lack a comparison group, so they can raise a question without answering it.
Put together, the evidence supports the common description of buspirone as weight-neutral for most people, while leaving room for individual exceptions.
Could BuSpar Change Your Appetite?
There’s one plausible way buspirone could nudge appetite. In the controlled stomach study, 17 people with functional dyspepsia, a condition marked by early fullness and bloating, took buspirone or placebo before meals for four weeks each. Buspirone relaxed the upper stomach, so it could comfortably hold more after a meal (229 mL versus 141 mL on placebo), and it reduced early fullness and bloating.
For someone whose anxiety shows up as a tight, full stomach, that effect might make meals easier. Whether it leads to eating more or gaining weight is unknown, because the study didn’t measure either. It’s a reasonable hypothesis, and it shouldn’t be read as proof.
Why People Gain Weight While Taking BuSpar
When the scale moves after starting buspirone, other explanations are usually more likely than the drug itself.
Buspirone is often added to an antidepressant. In the STAR*D study, a large depression treatment trial, 286 adults who hadn’t recovered on citalopram had buspirone added to it. If you take buspirone alongside an SSRI, the weight risk seen with antidepressants in the UK cohort may be the bigger factor. Our guides to Zoloft weight gain and Lexapro weight gain cover those patterns.
Depression and anxiety change appetite on their own. The National Institute of Mental Health lists changes in appetite or unplanned weight changes among common depression symptoms, and notes that sleep and appetite often improve before mood does once treatment starts working. If worry had been suppressing your appetite, eating normally again can look like a side effect.
Daily routines shift during treatment, too. Changes in sleep, activity, and drinking can all move your weight. If alcohol is part of the picture, our guide to buspirone and alcohol explains how the two interact.
What to Do If the Scale Moves
A few simple steps can help you and your prescriber sort out the cause:
- Weigh yourself once a week, at the same time of day, rather than daily.
- Note when you started buspirone and any other medication, including dose changes.
- Jot down appetite, sleep, and anxiety levels alongside your weight.
- Bring your full medication list, including supplements, to your next visit.
- Keep taking buspirone as prescribed until you’ve talked with your prescriber.
If buspirone does seem to be the cause, your prescriber can adjust the dose or discuss alternatives. For people who need to avoid weight gain, that conversation is worth having before switching to medications with a heavier weight profile, such as those covered in our guide to mirtazapine weight gain.
When to Call Your Prescriber or 911
Call 911 for swelling of the face, lips, tongue, or throat, or for trouble breathing, since the label reports rare allergic reactions including angioedema. Call or text 988 for thoughts of harming yourself. Contact your prescriber promptly for:
- Rapid weight gain with swelling in your hands, feet, or ankles
- Unintended weight loss or not eating because of nausea
- Chest pain, fainting, or a racing heart
- New or worsening depression or anxiety
With weight, a slow change over three months is easy to miss and hard to trace back to its cause once it’s noticed.
The evidence points in one direction: buspirone rarely causes weight change on its own, and when weight shifts during treatment, another medication, returning appetite, or everyday routines are more common reasons. Tracking the timeline gives you and your prescriber the best chance of finding the real cause. For a broader look at how BuSpar compares with an SSRI, see our guide to BuSpar vs Lexapro.
Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.
This article is for education only and isn’t a substitute for personal medical advice. Don’t start, change, or stop a medication without talking to your prescriber, except in an emergency described here. It was reviewed for clinical accuracy and reflects sources available as of September 2026.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
Does buspirone cause weight gain?
Weight gain is uncommon on buspirone. Its prescribing information lists weight gain as an infrequent side effect, reported in roughly 1 in 100 to 1 in 1,000 people across premarketing studies, and it didn't appear among side effects in placebo-controlled trials. Buspirone is generally considered weight-neutral, though individual experiences vary.
Can buspirone cause weight loss?
Weight loss on buspirone is also uncommon. The label lists weight loss and decreased appetite as infrequent side effects, at the same frequency as weight gain. Nausea is more common, affecting 8% of people in trials versus 5% on placebo, and can reduce how much you eat in the first weeks.
Does buspirone increase appetite?
Increased appetite is listed as an infrequent side effect in buspirone's label. A small study in people with functional dyspepsia found buspirone relaxed the upper stomach and reduced early fullness after meals, which could plausibly affect appetite, but that study didn't measure weight or food intake.
Is BuSpar better than SSRIs for weight?
BuSpar generally carries less weight risk than antidepressants as a group. Its label reports weight gain as infrequent, while a large UK cohort linked antidepressant prescriptions to a 21% higher rate of gaining at least 5% of body weight. No head-to-head trial has compared weight change on buspirone and SSRIs directly.
Why did I gain weight after starting BuSpar?
Weight gain after starting BuSpar often has another explanation. Common ones include an SSRI or other medication taken at the same time, appetite returning as depression or anxiety improves, and changes in sleep, activity, or drinking. Track when the change started and share that timeline with your prescriber.
Should I stop BuSpar if I gain weight?
Don't stop BuSpar on your own because of weight gain. Talk with your prescriber first, since the cause is often something other than buspirone and stopping could let anxiety symptoms return. Your prescriber can review your other medications, adjust the plan, or suggest alternatives if buspirone seems to be the cause.
Sources
- Mylan Pharmaceuticals Inc. Buspirone hydrochloride tablets prescribing information. DailyMed, U.S. National Library of Medicine. Revised June 2026. dailymed.nlm.nih.gov
- Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003;28(3):519-526. doi:10.1038/sj.npp.1300027
- Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ. 2018;361:k1951. doi:10.1136/bmj.k1951
- Wen Z, Liu X, Guo P, et al. Adverse events related to buspirone: a real-world pharmacovigilance study using the FAERS database. Journal of Affective Disorders. 2026;401:121240. doi:10.1016/j.jad.2026.121240
- Tack J, Janssen P, Masaoka T, Farré R, Van Oudenhove L. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clinical Gastroenterology and Hepatology. 2012;10(11):1239-1245. doi:10.1016/j.cgh.2012.06.036
- Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine. 2006;354(12):1243-1252. doi:10.1056/NEJMoa052964
- National Institute of Mental Health. Depression. NIH Publication No. 24-MH-8079. Revised 2024. nimh.nih.gov